Results 71 to 80 of about 741,475 (253)

Infection by Hepatitis Delta Virus [PDF]

open access: yesViruses, 2020
Hepatitis delta virus (HDV) and hepatitis B virus (HBV) are blood-borne viruses that infect human hepatocytes and cause significant liver disease. Infections with HBV are more damaging when there is a coinfection with HDV. The genomes and modes of replication of these two viruses are fundamentally different, except for the fact that, in nature, HDV ...
openaire   +3 more sources

Validation of Modified Albumin‐Bilirubin‐Tumor Stage as a Prognostic Model in Early‐Stage Hepatocellular Carcinoma Treated With Radiofrequency Ablation

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Survival after radiofrequency ablation (RFA) for very early‐ or early‐stage hepatocellular carcinoma (HCC) remains heterogeneous because prognosis depends on both tumor burden and hepatic reserve. We retrospectively evaluated treatment‐naive patients with Barcelona Clinic Liver Cancer (BCLC) Stages 0 or A HCC treated with RFA as initial ...
Cheng‐Ying Hsieh   +9 more
wiley   +1 more source

Delta High P.T.A. Officers

open access: yes, 1965
Left to Right: Mrs. Ronald Wright-Secretary, Mrs. Robert Clark-President, Mrs. Dorcey Sabey-Vice President being presented the P.T.A. duties by Mrs.

core   +1 more source

Prevalence of HDV, HCV, and HIV Infection in the Population of Patients Infected with HBV in a Romanian Cohort

open access: yesMicroorganisms
Hepatitis B virus (HBV) infections remain a significant global health challenge, especially in low- and middle-income countries where access to healthcare services is often limited.
Antoanela Curici   +2 more
doaj   +1 more source

Analysis of Carbohydrates and Glycoconjugates by Matrix‐Assisted Laser Desorption/Ionization Mass Spectrometry: An Update for 2023–2024

open access: yesMass Spectrometry Reviews, EarlyView.
ABSTRACT The use of MALDI mass spectrometry for the analysis of carbohydrates and glycoconjugates is a well‐established technique and this comprehensive review is the twelfth update of the original article published in 1999 and brings coverage of the literature to the end of 2024.
David J. Harvey
wiley   +1 more source

Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy

open access: yesDrug Design, Development and Therapy, 2023
Vicente Soriano,1 Victor Moreno-Torres,1,2 Ana Treviño,1 Octavio Corral,1 Carmen de Mendoza2 1Health Sciences School & Medical Center, Universidad Internacional La Rioja (UNIR), Madrid, Spain; 2Puerta de Hierro University Hospital & Research Institute ...
Soriano V   +4 more
doaj  

PREVALENCE AND SIGNIFICANCE OF ANTIBODY TO HEPATITIS C VIRUS (HCV) IN PATIENTS WITH CHRONIC HEPATITIS TYPE B AND DELTA

open access: yes, 1989
Prevalence and significance of antibody to hepatitis C virus (HCV) in patients with chronic hepatitis type B and delta is described. HCV worsen clinical course of paitents with chronic hepatitis type
Pontisso P.   +12 more
core  

Population Pharmacokinetics and Transfer of Gabapentin When Used as a Pain Adjunct for Cesarean Deliveries

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 551-560, March 2025.
ABSTRACT Enhanced Recovery After Surgery (ERAS) protocols for cesarean deliveries (CDs) utilize multimodal pain management strategies that often include gabapentin. While gabapentin is excreted in breast milk, its pharmacokinetics in immediately postpartum lactating women are not known. This observational pharmacokinetic study (NCT05099484) enrolled 21
Rebecca Silvola   +9 more
wiley   +1 more source

Prospects for Controlling Hepatitis B Globally

open access: yesPathogens
Infection with the hepatitis B virus (HBV) is highly prevalent globally. Over 250 million people suffer from chronic hepatitis B, and more than 800,000 patients die each year due to hepatitis B complications, including liver cancer.
Vicente Soriano   +5 more
doaj   +1 more source

Disease Progression Mathematical Modeling With a Case Study on Hepatitis B Virus Infection

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 420-434, March 2025.
ABSTRACT Chronic Hepatitis B presents a significant health and socioeconomic burden. The risk of hepatocellular carcinoma remains elevated although treatments are available. Achieving an optimal treatment regimen necessitates a deep comprehension of the dynamic relationship between the virus and its host across disease states.
Clémence Boivin‐Champeaux   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy